Sarah Schram

Stock Analyst at William Blair

(0.34)
# 4,315
Out of 5,102 analysts
1
Total ratings
n/a
Success rate
-5.98%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Sarah Schram

Denali Therapeutics
Jan 3, 2025
Initiates: Outperform
Price Target: n/a
Current: $17.37
Upside: -